Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million DealSeeking Alpha • 05/03/21
LogicBio Announces Presentation of Retrospective Study of Disease Course in Pediatric Patients with Severe Methylmalonic AcidemiaPRNewsWire • 05/03/21
AstraZeneca PLC's (AZN) CEO Pascal Soriot on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/01/21
AstraZeneca reveals COVID-19 vaccine sales but that isn't why the stock is risingMarket Watch • 04/30/21
AstraZeneca COVID-19 Vaccine Costs Hit Q1 Earnings; Cancer Meds, Emerging Markets Save The DayBenzinga • 04/30/21
AstraZeneca expects performance boost in second half after posting 15% quarterly revenue jumpProactive Investors • 04/30/21
AstraZeneca to show there is more to the company than the COVID-19 vaccineProactive Investors • 04/29/21
Coronavirus: One vaccine dose enough to cut transmission risk by half, AstraZeneca/EU legal challenge beginsProactive Investors • 04/28/21
Arix Bioscience investee LogicBio signs strategic collaboration with CANBridge PharmaProactive Investors • 04/27/21